New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
09:04 EDTALXAAlexza shares should be bought ahead of marketing decision, says Roth Capital
Roth Capital believes that Alexza's upcoming decision on a marketing route for its Adasuve treatment will most likely be positive for shareholders and the firm reiterates a Buy rating on the stock.
News For ALXA From The Last 14 Days
Check below for free stories on ALXA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
09:05 EDTALXAAlexza Pharmaceuticals updates five post-EMA approval studies for Adasuve
Subscribe for More Information
August 8, 2014
10:00 EDTALXAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:01 EDTALXAAlexza Pharmaceuticals announces launch of ADASUVE
Subscribe for More Information
06:38 EDTALXAAlexza Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
August 7, 2014
16:44 EDTALXAAlexza Pharmaceuticals reports Q2 EPS (34c), consensus (67c)
Reports Q2 revenue $1.5M, consensus $2.24M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use